Sonographic identification of down syndrome fetuses in the third trimester: A matched case-controlled study

1998 ◽  
Vol 5 (1) ◽  
pp. 166A-166A
Author(s):  
A RANZINI ◽  
C ANANTH ◽  
D DAYSALVATORE ◽  
A VINTZILEOS
Keyword(s):  
Down Syndrome ◽  
Controlled Study ◽  
Third Trimester ◽  
The Third ◽  
Matched Case

Down Syndrome and Omphalocele: An Underrecognized Association

PEDIATRICS ◽  
1994 ◽  
Vol 93 (3) ◽  
pp. 514-515
Author(s):  
Vinay N. Reddy ◽  
David J. Aughton ◽  
David B. DeWitte ◽  
Cheryl E. Harper
Keyword(s):  
Down Syndrome ◽  
Case Report ◽  
Cesarean Section ◽  
Muscle Tone ◽  
Bed Rest ◽  
Third Trimester ◽  
The Third ◽  
Face Presentation ◽  
Maternal Hypertension ◽  
Facial Edema

Omphalocele is associated with Down syndrome,1 and the concurrence of omphalocele and Down syndrome has been reported several times.1-8 However, these observations are not noted in standard genetic reference books (such as references 9 through 15), genetic databases (such as POSSUM), or pediatric textbooks (such as references 16 through 18). We report a further case of omphalocele associated with Down syndrome, in which the presence of this "atypical" major anomaly, combined with initially good muscle tone and marked but transient facial edema, led to a brief delay in recognizing the clinical diagnosis of Down syndrome. CASE REPORT The propositus was born to a 33-year-old, gravida 2, para 1 woman via primary cesarean section for face presentation after a 41-week pregnancy that was complicated by maternal hypertension and by premature onset of labor early in the third trimester, controlled by bed rest.

Prophylactic Lithium in Puerperal Psychosis

1991 ◽  
Vol 158 (3) ◽  
pp. 393-397 ◽  
Author(s):  
D. E. Stewart ◽  
J. L. Klompenhouwer ◽  
R. E. Kendell ◽  
A. M. Van Hulst
Keyword(s):  
Bipolar Disorder ◽  
High Risk ◽  
Lithium Carbonate ◽  
Controlled Study ◽  
Third Trimester ◽  
Psychotic Illness ◽  
Puerperal Psychosis ◽  
The Third ◽  
Larger Sample

At three centres, 21 women at high risk for puerperal psychosis were given prophylactic lithium carbonate late in the third trimester of pregnancy or immediately after delivery. Only two of the women had a recurrence of their psychotic illness while on prophylactic lithium. One woman given lithium during third trimester had an unexplained stillbirth. Although a larger sample in a carefully controlled study is still required, there now seems to be grounds for the use of prophylactic lithium immediately after delivery in women not breastfeeding who have previously suffered from either puerperal psychosis or bipolar disorder.

Sonographic Identification of Fetuses With Down Syndrome in the Third Trimester

1999 ◽  
Vol 93 (5, Part 1) ◽  
pp. 702-706
Author(s):  
ANGELA C. RANZINI ◽  
EDWIN R. GUZMAN ◽  
CANDE V. ANANTH ◽  
DEBRA DAY-SALVATORE ◽  
ALLAN J. FISHER ◽  
...  
Keyword(s):  
Down Syndrome ◽  
Third Trimester ◽  
The Third

Cervical ripening in the third trimester of pregnancy with intravaginal misoprostol: A double-blind, randomized, placebo-controlled study

1998 ◽  
Vol 18 (3) ◽  
pp. 183-186 ◽  
Author(s):  
Wang Zehua ◽  
Li Weiji ◽  
Ouyang Weixiang ◽  
Ding Yulian ◽  
Wang Feng ◽  
...  
Keyword(s):  
Cervical Ripening ◽  
Controlled Study ◽  
Third Trimester ◽  
Double Blind ◽  
The Third

Correlations Between the Values of Maternal Glycemia from the Last Trimester of Pregnancy and Fetal Birth Weight

2013 ◽  
Vol 20 (3) ◽  
pp. 259-265
Author(s):  
Monica Vereş ◽  
Aurel Babeş ◽  
Szidonia Lacziko
Keyword(s):  
First Trimester ◽  
Mean Value ◽  
Fetal Macrosomia ◽  
Entire Group ◽  
Third Trimester ◽  
The Third ◽  
Group I ◽  
Fetal Birth Weight ◽  
First Trimester Of Pregnancy ◽  
The Mean

Abstract Background and aims: Gestational diabetes represents a form of diabetes diagnosed during pregnancy that is not clearly overt diabetes. In the last trimester of gestation the growth of fetoplacental unit takes place, thus maternal hyperglycemia will determine an increased transplacental passage, hyperinsulinemia and fetal macrosomia. The aim of our study was that o analyzing the effect of maternal glycemia from the last trimester of pregnancy over fetal weight. Material and method: We run an observational study on a group of 46 pregnant women taken into evidence from the first trimester of pregnancy, separated in two groups according to blood glucose determined in the third trimester (before birth): group I normoglycemic and group II with hyperglycemia (>92mg/dl). Results: The mean value of third trimester glycemia for the entire group was of 87.13±22.03. The mean value of the glycemia determined in the third trimester of pregnancy was higher in the second group (109.17 mg/dl) in comparison to the first group (74.,21 mg/dl). The ROC curve for third trimester glycemia as fetal macrosomia appreciation test has an AUC of 0.517. Conclusions: Glycemia determined in the last trimester of pregnancy cannot be used alone as the predictive factor for fetal macrosomia.

Features of the course and treatment of glaucoma during pregnancy

2020 ◽  
Vol 98 (3) ◽  
pp. 178-184
Author(s):  
T. V. Chernyakova ◽  
A. Yu. Brezhnev ◽  
I. R. Gazizova ◽  
A. V. Kuroyedov ◽  
A. V. Seleznev
Keyword(s):  
Pregnant Women ◽  
Laser Treatment ◽  
Progressive Disease ◽  
Clinical Course ◽  
The Other ◽  
Third Trimester ◽  
The Third ◽  
Chronic Progressive Disease ◽  
Hypotensive Therapy ◽  
Eye Pressure

In the review we have integrated all up-to-date knowledge concerning clinical course and treatment of glaucoma among pregnant women to help specialists choose a proper policy of treatment for such a complicated group of patients. Glaucoma is a chronic progressive disease. It rarely occurs among childbearing aged women. Nevertheless the probability to manage pregnant patients having glaucoma has been recently increasing. The situation is complicated by the fact that there are no recommendations on how to treat glaucoma among pregnant women. As we know, eye pressure is progressively going down from the first to the third trimester, so we often have to correct hypotensive therapy. Besides, it is necessary to take into account the effect of applied medicines on mother health and evaluate possible teratogenic complications for a fetus. The only medicine against glaucoma which belongs to category B according to FDA classification is brimonidine. Medicines of the other groups should be prescribed with care. Laser treatment or surgery may also be a relevant decision when monitoring patients who are planning pregnancy or just bearing a child. Such treatment should be also accompanied by medicines.

Sign in / Sign up

Export Citation Format

Share Document